In this article: Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership, Staley, Kristina ; Ahmadi, Kourosh R ; Carter, Karyl ; Cowan, Katherine ; Seage, Heidi ; Visser, Petra ; Ward, Nicola ; Hooper, Martyn BMJ open, 2022, Vol.12 (8), p.e065166-e065166
the goal was to identify the top 10 important research priorities. They wanted open questions that those with pernicious anemia and medical professionals thought most needed addressing. Copied from the article, the list of 10 are:
1. Can a more reliable and accurate test be developed to diagnose PA?
2. Does an individual’s need for B12 treatment change over time or with life circumstances? What factors might affect this day to day (e.g, stress and exercise) and over a lifespan (e.g, ageing, menopause)?
3. What are the safest and most effective ways to give B12 to people with PA, tablets, sprays or injections, or a combination? Can better ways be developed?
4. Why do some health professionals fail to take PA seriously? How can this be addressed beyond improving awareness and knowledge of PA?
5. If the frequency, dose and timing of B12 injections were tailored to the individual and their symptoms, would this improve the health of people with PA?
6. Why do people with PA need B12 injections at different time intervals?
7. Why do some people with PA still experience symptoms after treatment with B12?
8. If people with PA do not receive B12 treatment according to their needs, does this cause harm or irreversible damage?
9. What should be included in a long-term, comprehensive treatment and care plan for people with PA?
10. Is PA linked to other health conditions, in particular autoimmune conditions or digestive problems? Is there a common cause?
I really hope that this stimulates some new research that gives us answers to these questions.